• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AQP4-IgG 水平和免疫标志物在 NMOSD 蛋白 A 免疫吸附治疗中的动态变化:病例报告及文献复习。

Dynamic Changes in AQP4-IgG Level and Immunological Markers During Protein-A Immunoadsorption Therapy for NMOSD: A Case Report and Literature Review.

机构信息

Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Front Immunol. 2021 Jul 21;12:650782. doi: 10.3389/fimmu.2021.650782. eCollection 2021.

DOI:10.3389/fimmu.2021.650782
PMID:34367127
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8334553/
Abstract

The changes in the serum levels of aquaporin-4-IgG (AQP4-IgG), immunoglobulins, and inflammatory mediators in neuromyelitis optica spectrum disorder (NMOSD) cases treated with immunoadsorption have been rarely described in detail. Here we report a 29-year-old steroid-resistant NMOSD female with a severe disability (bilateral blindness and paraplegia) who received protein-A immunoadsorption as a rescue treatment. During the total 5 sessions, the circulating level of AQP4-IgG, immunoglobulins, and complement proteins (C3 and C4) showed a rapid and sawtooth-like decrease, and the serum AQP4-IgG titer declined from 1:320 to below the detectable limit at the end of the 3rd procedure. Of all the antibodies, IgG had the biggest removal rate (>96.1%), followed by IgM (>66.7%) and IgA (53%), while complement C3 and C4 also dropped by 73% and 65%, respectively. The reduced pro-inflammatory cytokines (interleukin-8 and tumor necrosis factor-α) and marked increased lymphocyte (T and B cell) counts were also observed. The improvement of symptoms initiated after the last session, with a low AQP4-IgG titer (1:32) persisting thereafter. Accordingly, protein-A immunoadsorption treatment could be one of the potential rescue therapies for steroid-resistant NMOSD patients with a severe disability.

摘要

水通道蛋白 4 免疫球蛋白 G(AQP4-IgG)、免疫球蛋白和炎症介质在接受免疫吸附治疗的视神经脊髓炎谱系疾病(NMOSD)患者中的血清水平变化鲜有详细描述。在此,我们报告了 1 例 29 岁的女性类固醇耐药性 NMOSD 患者,病情严重(双侧失明和截瘫),接受蛋白 A 免疫吸附作为抢救治疗。在总共 5 个疗程中,AQP4-IgG、免疫球蛋白和补体蛋白(C3 和 C4)的循环水平呈快速锯齿状下降,血清 AQP4-IgG 滴度在第 3 次治疗结束时从 1:320 下降到检测不到。在所有抗体中,IgG 的清除率最高(>96.1%),其次是 IgM(>66.7%)和 IgA(53%),补体 C3 和 C4 也分别下降了 73%和 65%。促炎细胞因子(白细胞介素-8 和肿瘤坏死因子-α)减少,淋巴细胞(T 细胞和 B 细胞)计数明显增加。在最后一次治疗后症状开始改善,此后持续存在低 AQP4-IgG 滴度(1:32)。因此,蛋白 A 免疫吸附治疗可能是一种潜在的治疗类固醇耐药性 NMOSD 严重残疾患者的抢救治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c21f/8334553/efdee553bff6/fimmu-12-650782-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c21f/8334553/487a88083f1e/fimmu-12-650782-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c21f/8334553/28bae0486408/fimmu-12-650782-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c21f/8334553/efdee553bff6/fimmu-12-650782-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c21f/8334553/487a88083f1e/fimmu-12-650782-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c21f/8334553/28bae0486408/fimmu-12-650782-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c21f/8334553/efdee553bff6/fimmu-12-650782-g003.jpg

相似文献

1
Dynamic Changes in AQP4-IgG Level and Immunological Markers During Protein-A Immunoadsorption Therapy for NMOSD: A Case Report and Literature Review.AQP4-IgG 水平和免疫标志物在 NMOSD 蛋白 A 免疫吸附治疗中的动态变化:病例报告及文献复习。
Front Immunol. 2021 Jul 21;12:650782. doi: 10.3389/fimmu.2021.650782. eCollection 2021.
2
C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD.AQP4-IgG 阳性 NMOSD 和 MOGAD 患者的 C3 和 C4 补体水平。
J Neuroimmunol. 2021 Nov 15;360:577699. doi: 10.1016/j.jneuroim.2021.577699. Epub 2021 Aug 24.
3
The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.补体蛋白在区分 AQP4-IgG 阳性与 MOG-IgG 阳性视神经脊髓炎谱系疾病中的临床价值。
Mult Scler Relat Disord. 2019 Oct;35:1-4. doi: 10.1016/j.msard.2019.06.035. Epub 2019 Jun 29.
4
Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level.免疫吸附血浆置换治疗抗水通道蛋白4抗体水平波动的视神经脊髓炎谱系障碍复发加重期
J Artif Organs. 2018 Sep;21(3):378-382. doi: 10.1007/s10047-018-1044-3. Epub 2018 Apr 19.
5
Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.视神经脊髓炎谱系疾病伴髓鞘少突胶质细胞糖蛋白或水通道蛋白-4 抗体:阿尔及利亚患者的临床和辅助检查特征。
J Neurol Sci. 2017 Oct 15;381:240-244. doi: 10.1016/j.jns.2017.08.3254. Epub 2017 Aug 31.
6
Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder.AQP4-IgG 血清阳性视神经脊髓炎谱系疾病患者亚组血清中的细胞保护 IgG 抗体。
Sci Rep. 2021 Nov 9;11(1):21962. doi: 10.1038/s41598-021-01294-3.
7
Protein-A immunoadsorption combined with immunosuppressive treatment in refractory primary Sjögren's syndrome coexisting with NMOSD: a case report and literature review.蛋白 A 免疫吸附联合免疫抑制治疗难治性原发性干燥综合征合并 NMOSD:病例报告及文献复习。
Front Immunol. 2024 Jul 11;15:1429405. doi: 10.3389/fimmu.2024.1429405. eCollection 2024.
8
EBI2-expressing B cells in neuromyelitis optica spectrum disorder with AQP4-IgG: Association with acute attacks and serum cytokines.视神经脊髓炎谱系疾病中表达 EBI2 的 B 细胞与 AQP4-IgG:与急性发作和血清细胞因子的关联。
J Neuroimmunol. 2021 Sep 15;358:577637. doi: 10.1016/j.jneuroim.2021.577637. Epub 2021 Jun 22.
9
The complement and immunoglobulin levels in NMO patients.视神经脊髓炎患者的补体和免疫球蛋白水平。
Neurol Sci. 2014 Feb;35(2):215-20. doi: 10.1007/s10072-013-1481-y. Epub 2013 Jul 24.
10
Paraneoplastic AQP4-IgG-Seropositive Neuromyelitis Optica Spectrum Disorder Associated With Teratoma: A Case Report and Literature Review.副肿瘤性水通道蛋白 4 免疫球蛋白 G 阳性视神经脊髓炎谱系疾病伴畸胎瘤:病例报告及文献复习。
Neurol Neuroimmunol Neuroinflamm. 2021 Jul 20;8(5). doi: 10.1212/NXI.0000000000001045. Print 2021 Jul.

引用本文的文献

1
Immune checkpoint inhibitor-induced anti-Hu antibody-associated gastrointestinal pseudo-obstruction: a case report and literature review.免疫检查点抑制剂诱导的抗Hu抗体相关胃肠道假性梗阻:一例报告及文献综述。
Front Immunol. 2025 Apr 1;16:1555790. doi: 10.3389/fimmu.2025.1555790. eCollection 2025.
2
The EBV connection: a severe case of GFAP-A with central hypoventilation unresponsive to IVIG and literature review.EBV 相关:一例严重 GFAP-A 病例,伴中枢性通气不足,对 IVIG 治疗无效并文献复习。
Eur J Med Res. 2024 Aug 13;29(1):415. doi: 10.1186/s40001-024-01926-0.
3
Protein-A immunoadsorption combined with immunosuppressive treatment in refractory primary Sjögren's syndrome coexisting with NMOSD: a case report and literature review.

本文引用的文献

1
A case of anti-aquaporin-4 antibody-positive optic neuritis treated by selective immunoadsorption.抗水通道蛋白-4 抗体阳性视神经炎的选择性免疫吸附治疗病例。
Transfus Apher Sci. 2021 Feb;60(1):102969. doi: 10.1016/j.transci.2020.102969. Epub 2020 Oct 20.
2
Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology.白细胞介素-6 在视神经脊髓炎谱系疾病发病机制中的作用。
Neurol Neuroimmunol Neuroinflamm. 2020 Aug 20;7(5). doi: 10.1212/NXI.0000000000000841. Print 2020 Sep 3.
3
High-throughput investigation of molecular and cellular biomarkers in NMOSD.
蛋白 A 免疫吸附联合免疫抑制治疗难治性原发性干燥综合征合并 NMOSD:病例报告及文献复习。
Front Immunol. 2024 Jul 11;15:1429405. doi: 10.3389/fimmu.2024.1429405. eCollection 2024.
4
Efficacy and safety of apheresis therapy in AQP4 antibody-positive NMOSD attack: A propensity score-matched cohort study.AQP4 抗体阳性 NMOSD 发作时的血浆吸附疗法的疗效和安全性:一项倾向评分匹配队列研究。
CNS Neurosci Ther. 2024 May;30(5):e14780. doi: 10.1111/cns.14780.
对 NMOSD 中的分子和细胞生物标志物进行高通量研究。
Neurol Neuroimmunol Neuroinflamm. 2020 Aug 4;7(5). doi: 10.1212/NXI.0000000000000852. Print 2020 Sep.
4
The differential expression of natural killer cells in NMOSD and MS.自然杀伤细胞在 NMOSD 和 MS 中的差异表达。
J Clin Neurosci. 2020 Jan;71:9-14. doi: 10.1016/j.jocn.2019.11.022. Epub 2019 Dec 18.
5
Analysis of the Complement System in the Clinical Immunology Laboratory.临床免疫实验室中的补体系统分析
Clin Lab Med. 2019 Dec;39(4):579-590. doi: 10.1016/j.cll.2019.07.006. Epub 2019 Oct 3.
6
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.抗水通道蛋白 4 抗体阳性视神经脊髓炎谱系疾病的治疗
N Engl J Med. 2019 Aug 15;381(7):614-625. doi: 10.1056/NEJMoa1900866. Epub 2019 May 3.
7
Effects of immunoadsorption combined with membrane filtration on complement markers - results of a randomized, controlled, crossover study.免疫吸附联合膜过滤对补体标志物的影响:一项随机、对照、交叉研究的结果。
Transpl Int. 2019 Aug;32(8):876-883. doi: 10.1111/tri.13431. Epub 2019 Apr 5.
8
Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions.用于治疗视神经脊髓炎谱系障碍(NMOSD)发作的单采疗法:一项对207次治疗干预的回顾性研究。
Neurol Neuroimmunol Neuroinflamm. 2018 Sep 26;5(6):e504. doi: 10.1212/NXI.0000000000000504. eCollection 2018 Nov.
9
Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level.免疫吸附血浆置换治疗抗水通道蛋白4抗体水平波动的视神经脊髓炎谱系障碍复发加重期
J Artif Organs. 2018 Sep;21(3):378-382. doi: 10.1007/s10047-018-1044-3. Epub 2018 Apr 19.
10
Immunoadsorption in neurological disorders.神经疾病中的免疫吸附
Transfus Apher Sci. 2017 Oct;56(5):671-676. doi: 10.1016/j.transci.2017.08.013. Epub 2017 Aug 26.